Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium
- 1 December 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (12) , 2738-2742
- https://doi.org/10.1128/aac.38.12.2738
Abstract
The combined effect of clarithromycin and rifabutin against Mycobacterium avium multiplying either within human monocyte-derived macrophages or extracellularly in a liquid medium was additive: both MICs and MBCs were twofold lower for the combination than they were for each drug alone. Prolonged exposure for 4 weeks of M. avium-infected macrophages to combined concentrations that were only twofold greater than the MICs resulted in a 100-fold decrease in the number of viable bacteria, while in the drug-free controls a 100-fold or greater increase in comparison with the initial viable counts took place. Comparison of this effect with the results of the prolonged exposure to each drug alone suggested that under these experimental conditions rifabutin enhanced the antimicrobial activity of clarithromycin against intracellular bacteria. At the same time, inhibition of intracellular growth by a 2-h pulsed exposure of the infected macrophages to the combination of the two drugs was not different from the effect induced by clarithromycin alone. In conclusion, clarithromycin played the major role in the antimicrobial activity of the tested combination, while rifabutin may have enhanced this effect during a prolonged exposure of the intracellular bacteria to these two agents.Keywords
This publication has 13 references indexed in Scilit:
- Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophagesAntimicrobial Agents and Chemotherapy, 1994
- Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycinAntimicrobial Agents and Chemotherapy, 1993
- MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophagesAntimicrobial Agents and Chemotherapy, 1993
- The in-vitro bactericidal activities of combinations of antimicrobial agents against clinical isolates of Mycobacterium avium-intracellulareJournal of Antimicrobial Chemotherapy, 1992
- Clarithromycin Minimal Inhibitory and Bactericidal Concentrations againstMycobacterium aviumAmerican Review of Respiratory Disease, 1992
- Activityin vitroof Rifabutin, FCE 22807, Rifapentine, and Rifampin againstMycobacterium microtiandM. tuberculosisand Their Penetration into Mouse Peritoneal MacrophagesAmerican Review of Respiratory Disease, 1992
- Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophagesAntimicrobial Agents and Chemotherapy, 1991
- Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1991
- Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsAntimicrobial Agents and Chemotherapy, 1985
- THE PENETRATION OF RIFAMPICIN, PYRAZINAMIDE, AND PYRAZINOIC ACID INTO MOUSE MACROPHAGESPublished by Elsevier ,1985